VOYAGEUR PHARMACEUTICALS LTD (VM.CA) Forecast, Price Target & Analyst Ratings
TSX-V:VM • CA92918C1014
Current stock price
0.135 CAD
+0.01 (+8%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VOYAGEUR PHARMACEUTICALS LTD (VM.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.14 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
VM.CA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VM.CA.
In the previous month the buy percentage consensus was at a similar level.
VM.CA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-03-22 | Fundamental Research | Upgrade | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | |||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | -552.8K | -999.5K -80.81% | -2.049M -105.02% | -1.749M 14.65% | -1.344M 23.14% | -1.698M -26.30% | |
| EBIT YoY % growth | -94.5K | -1.5K 98.41% | -52.3K -3,386.67% | -866K -1,555.83% | -554.9K 35.92% | -1.001M -80.39% | -2.052M -104.95% | -1.752M 14.60% | -1.346M 23.15% | -1.699M -26.21% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A